Zobrazeno 1 - 10
of 790
pro vyhledávání: '"Le Vu S"'
Autor:
Le Vu S; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France. stephane.le-vu@ansm.sante.fr., Bertrand M; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Semenzato L; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Jabagi MJ; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Botton J; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France.; Faculté de Pharmacie, Université Paris-Saclay, Orsay, France., Drouin J; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Weill A; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Dray-Spira R; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Zureik M; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France.; University Paris-Saclay, UVSQ, University Paris-Sud, Inserm, Anti-infective evasion and pharmacoepidemiology, CESP, Montigny le Bretonneux, France.
Publikováno v:
Nature communications [Nat Commun] 2024 Sep 05; Vol. 15 (1), pp. 7745. Date of Electronic Publication: 2024 Sep 05.
Autor:
Sevin, T., Daniau, C., Alfandari, S., Piednoir, E., Dumartin, C., Blanchard, H., Simon, L., Berger-Carbonne, A., Le Vu, S.
Publikováno v:
In Journal of Hospital Infection August 2021 114:104-110
Autor:
Botton J; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France; Université Paris-Saclay, Faculté de pharmacie, Orsay 91400, France. Electronic address: jeremie.botton@ansm.sante.fr., Bertrand M; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Jabagi MJ; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Duranteau L; Department of Medical Gynecology, Bicêtre Hospital, AP.HP University Paris-Saclay, 94270 Le Kremlin Bicêtre, France., Bouillon K; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Drouin J; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Semenzato L; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Le Vu S; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Weill A; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France., Zureik M; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France; University Paris-Saclay, UVSQ, University Paris-Sud, Inserm, Anti-infective evasion and pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Dray-Spira R; EPIPHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products - ANSM, French National Health Insurance - CNAM), Saint-Denis, France.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126252. Date of Electronic Publication: 2024 Sep 02.
Autor:
Semenzato L; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Le Vu S; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Botton J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance.; University Paris-Saclay, Faculté de pharmacie, Orsay, France., Bertrand M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Jabagi MJ; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Drouin J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Cuenot F; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Zores F; Cardiologist, Specialized Medical Group, Strasbourg, France.; Centre Ellipse, Strasbourg, France., Dray-Spira R; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Weill A; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance., Zureik M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance.; University Paris-Saclay, UVSQ, University Paris-Sud, Inserm, Anti-infective evasion and Pharmacoepidemiology Unit/Team, CESP, Montigny le Bretonneux, France.
Publikováno v:
JAMA [JAMA] 2024 Aug 26. Date of Electronic Publication: 2024 Aug 26.
Autor:
Turpin A; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Semenzato L; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Le Vu S; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Jabagi MJ; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Bouillon K; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Drouin J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Bertrand M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Kanagaratnam L; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Weill A; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Dray-Spira R; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France., Zureik M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France; University Paris-Saclay, UVSQ, University Paris-Sud, Inserm, Anti-infective evasion and Pharmacoepidemiology Unit/Team, CESP, 78180 Montigny le Bretonneux, France., Botton J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National, Agency for the Safety of Medicines and Health Products and the French National Health Insurance, France; Faculty of Pharmacy, Paris-Saclay University, Orsay, France. Electronic address: jeremie.botton@ansm.sante.fr.
Publikováno v:
Journal of infection and public health [J Infect Public Health] 2024 Jul; Vol. 17 (7), pp. 102450. Date of Electronic Publication: 2024 May 14.
Autor:
Semenzato, L., Le Vu, S., Botton, J., Jabagi, M-J., Drouin, J., Cuenot, F., Zores, F., Dray-Spira, R., Weill, A., Zureik, M.
Publikováno v:
In Journal of Epidemiology and Population Health March 2024 72 Supplement 1
Autor:
Bougeard S; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., Huneau-Salaun A; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., Attia M; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Richard JB; Data Support, Processing and Analysis Department, Santé publique France, Saint-Maurice, France., Demeret C; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Platon J; Data Support, Processing and Analysis Department, Santé publique France, Saint-Maurice, France., Allain V; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., Le Vu S; EPI-PHARE, Saint-Denis, France., Goyard S; Diagnostic Test Innovation and Development Core Facility, Institut Pasteur, Paris, France., Gillon V; Clinical Immunology Laboratory, Institut Curie, Paris, France., Bernard-Stoecklin S; Infectious Disease Division, Santé publique France, Saint-Maurice, France., Crescenzo-Chaigne B; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Jones G; Infectious Disease Division, Santé publique France, Saint-Maurice, France., Rose N; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., van der Werf S; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Lantz O; Clinical Immunology Laboratory, Institut Curie, Paris, France., Rose T; Diagnostic Test Innovation and Development Core Facility, Institut Pasteur, Paris, France., Noël H; Infectious Disease Division, Santé publique France, Saint-Maurice, France.
Publikováno v:
JMIR public health and surveillance [JMIR Public Health Surveill] 2023 Nov 28; Vol. 9, pp. e46898. Date of Electronic Publication: 2023 Nov 28.
Autor:
Le Vu S; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France. stephane.le-vu@ansm.sante.fr., Bertrand M; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Botton J; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Jabagi MJ; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Drouin J; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Semenzato L; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Weill A; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Dray-Spira R; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France., Zureik M; From the EPI-PHARE Scientific Interest Group in Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], French National Health Insurance [CNAM]) (S.L.V., M.B., J.B., M.-J.J., J.D., L.S., A.W., R.D.-S., M.Z.), Saint-Denis; Université Paris-Saclay (J.B.), Faculté de Pharmacie, Orsay; and University Paris-Saclay (M.Z.), UVSQ, University Paris-Sud, Inserm, Anti-Infective Evasion and Pharmacoepidemiology, CESP, Montigny le Bretonneux, France.
Publikováno v:
Neurology [Neurology] 2023 Nov 21; Vol. 101 (21), pp. e2094-e2102. Date of Electronic Publication: 2023 Oct 03.
Publikováno v:
Biometrics, 2011 Jun 01. 67(2), 467-475.
Externí odkaz:
http://dx.doi.org/10.1111/j.1541-0420.2010.01473.x
Autor:
Semenzato L; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France., Botton J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France.; Faculty of Pharmacy, Paris-Saclay University, Orsay, France., Le Vu S; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France., Jabagi MJ; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France., Cuenot F; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France., Drouin J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France., Dray-Spira R; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France., Weill A; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France., Zureik M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, Saint-Denis, France.; Paris-Saclay University, UVSQ, Paris-Sud University, Inserm, Anti-infective Evasion and Pharmacoepidemiology Unit/Team, CESP, Montigny le Bretonneux, France.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Sep 08; Vol. 10 (10), pp. ofad460. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).